Bering, Aimelyn D.
HRN: 21-27-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2022
CEFUROXIME 500MG (TAB)
04/22/2022
04/28/2022
PO
500mg
BID
S/P Suction Curettage
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes